Novo Nordisk’s Sales Surge: Eyeing $7B Annual Investment
Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...
- Latest
- Trending
Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...
Shell Nigeria has resumed oil supply to the Port Harcourt Refinery after a five-year outage, reducing the country's dependence on ...
enCore Energy Corp. has eliminated its debt by converting a promissory note into common shares, becoming debt-free and positioning itself ...
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...
Analysts predict AI-integrated iPhones could boost Apple's stock and sales, potentially leading to more device replacements and revenue opportunities.
Renowned analyst Eric Krown predicts Ethereum's rally will continue towards the low $3000s, highlighting its strength, bullish technical indicators, and ...
Actively managed strategies and AI investments are fueling growth in the ETF industry. The industry is expanding its offerings and ...
Saudi Arabia's state-oil giant, Aramco, is considering a share sale in 2024, pending shareholder approval. This could lead to further ...
Oppenheimer lowers price target on Gilead Sciences after Q4 earnings report and challenges in drug pipeline. Optimistic about prospects for ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.